General Mills initiates 'transformation' programme with embedded costs
In a filing with the US Securities and Exchange Commission yesterday (27 May), the Blue Buffalo pet food and Cheerios cereals brand owner said the 'multi-year' plan was approved by management on 20 May.
It is 'intended to drive increased productivity by enhancing end-to-end business processes, enabled by targeted organisational actions'.
Although light on detail, the initiative comes on the back of a poor set of results reported in March for the third quarter of General Mills' current 2025 fiscal year. And the company suggested yesterday the transformation programme will be accompanied by job cuts.
Sales for the period dropped 5% in organic terms, a performance the company admitted fell short of 'expectations', with volumes down four percentage points.
At the same time, General Mills downgraded its full-year guidance for a flat-to-higher print confirmed at the second-quarter stage in December. The Pillsbury cookies maker now expects organic sales to be down 1.5% to 2%.
General Mills said yesterday that of the expected $130m in total charges, about $70m will be booked in the fourth quarter of 2025, 'primarily reflecting severance expenses'.
The Old El Paso Mexican brand owner explained in the filing: 'The company anticipates that the series of actions related to the transformation initiative will be substantially completed by the end of fiscal 2028 and will result in total charges of approximately $130 million, of which approximately $120 million will be cash.'
General Mills did not reveal any further details but implied in yesterday's filings that the initiative could have more in-depth implications.
'The estimate of costs that the company expects to record, and the timing thereof, are subject to a number of assumptions and actual results may differ from current expectations,' the publicly listed business added.
'The company may also record other charges or cash expenditures not currently contemplated due to events that may occur as a result of, or associated with, the transformation initiative.'
Discussing the third-quarter results in March, chairman and CEO Jeff Harmening made a pledge to reinvest $100m from targeted savings in the 2026 financial year.
'We're reviewing new cost-efficiency initiatives that are anticipated to generate at least $100 million in additional savings in fiscal '26, with further savings expected in fiscal '27 and beyond,' Harmening explained.
'Our number one priority is to accelerate our organic sales growth by delivering remarkable consumer experiences across our leading food brands, resulting in stronger volume and improved market share performance.'
General Mills is on target to generate 5% in cost-of-goods sold savings in the current year through the company's Holistic Margin Management (HMM) programme and expects to repeat that in fiscal 2026, equating to more than $600m in 'gross productivity savings', Harmening said in March.
"General Mills initiates 'transformation' programme with embedded costs" was originally created and published by Just Food, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Los Angeles Times
7 hours ago
- Los Angeles Times
U.S. sanctions Mexican drug cartel associates accused of scamming elderly Americans
MEXICO CITY — The U.S. Treasury Department imposed sanctions Wednesday on more than a dozen Mexican companies and four people it says worked with a powerful drug trafficking cartel to scam elderly Americans in a multimillion-dollar timeshare fraud. The network of 13 businesses in areas near the seaside tourist destination of Puerto Vallarta were accused of working with the Jalisco New Generation Cartel, a group designated by the U.S. government as a foreign terrorist organization. In a scheme dating back to 2012, four cartel associates are accused of defrauding American citizens of their life savings through elaborate rental and resale schemes, according to a Treasury statement. In the span of six months, officials said they were able to document $23.1 million sent from mostly people in the U.S. to scammers in Mexico. The sanctions imposed by the administration of President Trump would prohibit Americans from doing business with the alleged cartel associates and block any of their assets in the U.S. 'We will continue our effort to completely eradicate the cartels' ability to generate revenue, including their efforts to prey on elderly Americans through timeshare fraud,' U.S. Treasury Secretary Scott Bessent said in a statement. In past years, the administration of then-President Biden also sanctioned associates and accountants related to such schemes. The Wednesday announcement was made amid an ongoing effort by the Trump administration and the Mexican government to crack down on cartels and their diverse sources of income. The U.S. Treasury Department has slapped sanctions on a variety of people from a Mexican rapper who it accused of laundering cartel money to Mexican banks facilitating money transfers in sales of precursor chemicals used to produce fentanyl. The announcement also came one day after Mexico sent 26 high-ranking cartel figures to the U.S. in the latest major deal with the Trump administration as Mexico tries to avoid threatened tariffs.
Yahoo
12 hours ago
- Yahoo
U.S. Sanctions CJNG Cartel For $300M Timeshare Fraud Targeting Seniors
On Wednesday, the U.S. Treasury Department sanctioned four Mexican individuals and 13 companies linked to timeshare fraud schemes run by the Cartel de Jalisco Nueva Generacion (CJNG). The action targets operations based in Puerto Vallarta that prey on elderly Americans. CJNG, designated as a Foreign Terrorist Organization, has expanded beyond drug trafficking to generate revenue through elaborate timeshare scams that have cost U.S. victims nearly $300 million since 2019. 'We are coming for terrorist drug cartels like Cartel de Jalisco Nueva Generacion that are flooding our country with fentanyl,' said Treasury Secretary Scott Bessent. 'These cartels continue to create new ways to generate revenue to fuel their terrorist operations. At President Trump's direction, we will continue our effort to completely eradicate the cartels' ability to generate revenue, including their efforts to prey on elderly Americans through timeshare fraud.' The scams follow a devastating pattern. Cartel-run call centers obtain timeshare owner information from resort insiders, then contact victims claiming to be brokers or attorneys. They promise to sell timeshares or secure rental income but demand upfront 'fees' and 'taxes' that victims wire to Mexican bank accounts. The promised money supposedly owed to the owners never materializes, yet victims are pressed for additional payments. Some schemes stretch for years. Re-victimization scams follow, with fraudsters impersonating law firms offering to recover losses or government officials threatening imprisonment without payment of 'fines.' The FBI received nearly 900 timeshare fraud complaints in 2024 alone, reporting losses exceeding $50 million. Officials believe actual losses are far higher since most victims don't report due to embarrassment, among other reasons. CJNG seized control of Puerto Vallarta's timeshare fraud operations around 2012. The cartel employs English-fluent telemarketers and accountants to execute complex schemes targeting older Americans' life savings. Three senior CJNG members lead the fraud operations: Julio Cesar Montero Pinzon, Carlos Andres Rivera Varela, and Francisco Javier Gudino Haro. These men also orchestrate assassinations for the cartel's enforcement group using military-grade weapons. Michael Ibarra Diaz Jr., a Puerto Vallarta businessman with 20 years in the timeshare industry, was also sanctioned. His network includes 13 companies spanning real estate, travel agencies, tour operators, and accounting firms. Five companies explicitly acknowledge timeshare involvement: Akali Realtors, Centro Mediador De La Costa, Corporativo Integral De La Costa, Corporativo Costa Norte, and Sunmex Travel. Others mask their activities behind tourism and real estate fronts. The Treasury's action freezes all U.S. property belonging to the designated individuals and companies. American citizens are prohibited from conducting transactions with them. Financial institutions risk secondary sanctions for knowingly facilitating transactions with the sanctioned parties. The Treasury can prohibit foreign banks from maintaining U.S. correspondent accounts if they assist designated persons. This marks the Treasury's fifth action against CJNG timeshare fraud, bringing total designations to over 70 individuals and entities. Previous sanctions occurred in March 2023, April 2023, November 2023, and July 2024. CJNG ranks among the world's most powerful cartels. The group attacks Mexican military and police with military weapons, drops explosives from drones, and executes defiant recruits. Beyond drug trafficking, CJNG generates revenue through fuel theft, extortion, and human smuggling. Treasury continues targeting these diverse income streams alongside the FBI, DEA, and Mexican financial intelligence partners. Officials urge timeshare owners to exercise caution. Unsolicited purchase offers that seem too good to be true probably are fraudulent attempts to steal money. Victims should file complaints at Elderly victims can call the National Elder Fraud Hotline at 833-FRAUD-11 for assistance and resources. Solve the daily Crossword
Yahoo
14 hours ago
- Yahoo
Mexico Microcarrier Market Trends and Company Analysis Report 2025-2033 Featuring BD, Thermo Fisher Scientific, Merck, Eppendorf, Danaher, Sartorius, Bio Rad, Corning, Lonza Group, Getinge
The Mexico Microcarrier Market is poised for significant growth, projected to reach US$ 77.65 million by 2033 from US$ 39.96 million in 2024, achieving a CAGR of 7.66% from 2025 to 2033. Key drivers include increased investment in regenerative medicine and cell therapy, rising demand for cell-based vaccines and biologics, and technological advancements in cell culture efficiency. Mexico's biopharmaceutical sector expansion, supported by enhanced bioprocessing infrastructure and strategic public-private partnerships, further bolsters this growth. Emerging challenges include high setup costs and complex regulatory requirements, offering opportunities for innovation and collaboration. Mexican Microcarrier Market Dublin, Aug. 13, 2025 (GLOBE NEWSWIRE) -- The "Mexico Microcarrier Market to Reach US$ 77.65 Million by 2033 - 7.66% CAGR Growth Driven by Biopharma Demand" report has been added to Mexico Microcarrier Market is expected to reach US$ 77.65 million by 2033 from US$ 39.96 million in 2024, with a CAGR of 7.66% from 2025 to 2033. Growing investment in regenerative medicine and cell therapy, growing demand for cell-based vaccines and biologics, technological advancements in culture efficiency, and expansion of biopharmaceutical research and development in Mexico. Mexico's growing biopharmaceutical and biotechnology industries depend heavily on the microcarrier industry. The large-scale manufacturing of biologics, vaccines, and cell treatments depends on microcarriers, which are tiny, spherical particles that promote the proliferation of adherent cells in bioreactors. As Mexico looks to improve its local manufacturing capabilities in response to growing healthcare demands and the need for medical product self-sufficiency, these applications become more and more market is expanding due to a number of causes. Research and development expenditures, along with the nation's strategic efforts to strengthen its biomanufacturing infrastructure, are essential. The need for effective cell culture systems is further fueled by the aging population and the rising incidence of chronic diseases, which increase demand for cutting-edge treatment solutions. Additionally, Mexico has easier access to cutting-edge biotechnologies, such as microcarrier-based cell culture systems, thanks to its involvement in international health programs and collaborations with foreign the encouraging growth trajectory, the Mexican microcarrier market still confronts obstacles including the requirement for specialized technological know-how and the development of strong regulatory frameworks to guarantee the quality and safety of the products. Nonetheless, these difficulties offer chances for creativity and cooperation. These problems can be resolved by creating training initiatives, establishing regulatory guidelines, and encouraging public-private partnerships. This will create an atmosphere that is favorable for the expansion of the microcarrier market and the larger biopharmaceutical sector in Factors Driving the Mexico Microcarrier Market Growth Increasing Demand for Cell Therapy and BiopharmaceuticalsMicrocarrier systems are in high demand due to Mexico's growing biopharmaceutical industry, which includes the manufacture of vaccines, biologics, and cell treatments. Businesses are depending more and more on microcarriers to sustain high density adherent cell cultures in bioreactors as local R&D becomes more intense and manufacturing capacity need is particularly noticeable in the creation of therapeutic proteins, monoclonal antibodies, and items related to regenerative medicine. Scalable and effective cell culture is made possible by microcarriers, which is necessary for the commercial production of biologics and sophisticated cell culture systems are now a vital enabling technology for Mexico's biomanufacturing efforts as the nation develops its capacities in these fields and aligns with international health Development and Manufacturing ExpansionMexico's bioprocessing infrastructure is being quickly strengthened through government sponsored initiatives and strategic public-private partnerships. The adoption of effective cell culture technologies is being fueled by investments in upstream bioprocessing facilities, automation, single use systems, and digital technology is also supported by the growth of industry academia partnership and regulatory modernization (e.g., COFEPRIS's digital transformation). These advancements promote easier technology transfer from research to production and improve the technical preparedness required for microcarrier is therefore better able to scale complex bioprocesses, which increases the accessibility of microcarriers for biotechnology companies, contract manufacturers, and academic institutions seeking to increase their capacity for and Technological Progress in MicrocarriersPerformance and scalability have been greatly enhanced by innovations in microcarrier design, such as surface functionalized beads, biodegradable materials, and compatibility with single use bioreactors. Manufacturers who prioritize quality and cost effectiveness are placing a greater value on enhanced features like increased yield, better cell adhesion, and lower contamination developments, when combined with automation, intelligent sensor integration, and digital process control, reduce human error and streamline production. Modern microcarrier formats are becoming feasible choices for biomanufacturers and researchers nation wide due to Mexico's rising alignment with international industry trends and the country's expanding adoption of state of the art bioprocessing in the Mexico Microcarrier Market Expensive Startup and Ongoing CostsMicrocarrier based cell culture system deployment requires a large financial outlay, especially for equipment such as bioreactors, single use systems, and associated infrastructure. Traditional planar culture techniques are still less expensive at lower scales because they require less like microcarrier beads make up a significant portion of the continuous expenses for microcarrier setups, which frequently require tens or even hundreds of thousands of dollars in capital expenditure. GMP grade, high quality microcarriers can account for 20-25% of total consumable financial barriers, in addition to media supplies and labor training, make the technology hard to adopt in Mexico, where a large number of biotech companies and academic institutions have tight budgets. Despite the long term productivity and efficiency benefits of microcarriers, this hinders scale of Regulations and Documentation NeedsUnder the General Health Law, COFEPRIS is in charge of regulating microcarrier based cell culture in Mexico, particularly when it is meant for clinical or therapeutic applications. In accordance with ICH guidelines, businesses are required to compile comprehensive Common Technical Document (CTD) dossiers that include clinical, non clinical, and quality is necessary to adhere to Official Mexican Standards (such as NOM?257?SSA1?2014, NOM?059?SSA1?2015), especially those that deal with GMP, bio comparability, and safety assessment. Microcarrier systems need to be thoroughly validated, which includes testing for batch uniformity, sterility, and cell material obstacles to commercialization include the burden of complicated documentation and testing, changing regulations, and unclear advanced therapeutic standards. Market access may be delayed, more expensive, and unclear for entities without local regulatory partnerships or past dossier experience. Company Analysis: Overview, Key Persons, Recent Developments, SWOT Analysis, Revenue Analysis Thermo Fisher Scientific Merck KGaA Eppendorf AG Danaher Corporation Sartorius AG Bio Rad Laboratories, Inc. Corning Inc. Lonza Group Getinge Becton, Dickinson and Company Key Attributes: Report Attribute Details No. of Pages 200 Forecast Period 2024 - 2033 Estimated Market Value (USD) in 2024 $39.96 Million Forecasted Market Value (USD) by 2033 $77.65 Million Compound Annual Growth Rate 7.6% Regions Covered Mexico Key Topics Covered: 1. Introduction2. Research & Methodology2.1 Data Source2.1.1 Primary Sources2.1.2 Secondary Sources2.2 Research Approach2.2.1 Top-Down Approach2.2.2 Bottom-Up Approach2.3 Forecast Projection Methodology3. Executive Summary4. Market Dynamics4.1 Growth Drivers4.2 Challenges5. Mexico Microcarrier Market5.1 Historical Market Trends5.2 Market Forecast6. Market Share Analysis6.1 By Product Type6.2 By Application6.3 By End User6.4 By Region7. Product Type7.1 Consumables7.1.1 Microcarrier Beads7.1.2 Media & Reagents7.2 Equipment8. Application8.1 Cell Therapy8.1.1 Market Analysis8.1.2 Market Size & Forecast8.2 Vaccine Manufacturing8.3 Others9. End User9.1 Pharmaceutical & Biotechnology Companies9.2 Contract Research Organizations & Contract Manufacturing Organizations9.3 Academic & Research Institutes10. Region10.1 Northern Mexico10.2 Central Mexico10.3 Southern Mexico10.4 Others11. Value Chain Analysis12. Porter's Five Forces Analysis12.1 Bargaining Power of Buyers12.2 Bargaining Power of Suppliers12.3 Degree of Competition12.4 Threat of New Entrants12.5 Threat of Substitutes13. SWOT Analysis13.1 Strength13.2 Weakness13.3 Opportunity13.4 Threats14. Pricing Benchmark Analysis14.1 Thermo Fisher Scientific14.2 Merck KGaA14.3 Eppendorf AG14.4 Danaher Corporation14.5 Sartorius AG14.6 Bio-Rad Laboratories, Inc.14.7 Corning Inc.14.8 Lonza Group14.9 Getinge14.10 Becton, Dickinson and Company15. Key Players Analysis For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Mexican Microcarrier Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
